A monocenter, open-label glucose clamp study examining the metabolic effect of insulin infusion intervals for basal insulin infusion in patients with type-1 diabetes.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 03 Mar 2016 Biomarkers information updated
- 18 Jun 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health)
- 10 Jun 2010 Planned number of patients (14) added as reported by Roche record.